JAMES MCLENNAN: Open Payments
NPI 1487004511 · CASPER, WY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,326 in 116 payments from 19 companies in 2025. Trend: 2023 $2,668 · 2024 $2,726 · 2025 $3,326
Food & beverage: $3,326
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 25 | $746 |
| ABBVIE INC. | 14 | $359 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $349 |
| Bayer Healthcare Pharmaceuticals Inc. | 8 | $302 |
| Corcept Therapeutics | 14 | $279 |
| Novo Nordisk Inc | 6 | $216 |
| Lilly USA, LLC | 6 | $211 |
| Xeris Pharmaceuticals, Inc. | 1 | $198 |
| Exact Sciences Corporation | 7 | $137 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $101 |
Products named: CAPLYTA, FARXIGA, VRAYLAR, Kerendia, Korlym, BREZTRI, RECORLEV, Cologuard Collection Kit.
Industry payments across WY — which companies pay providers there.
